Hexa Research
Fact-based market research, penetrating industry insights and validated forecasts to help you make better decisions for a stronger future
rapidly growing segment due to the efficacy of nano particles to fight against cancerous tissues & tumors.
Browse Details of Report @ https:// www. hexaresearch. com / research-report / healthcarenanotechnology-industry
High incidence of cardiovascular anomalies can augment the cardiovascular segment over the forecast period. The market for nanotechnology applications in cardiology holds high growth potential in most developing & underdeveloped economies. The anti-infective segment is projected to expand considerably because of rising prevalence of air-borne diseases, bird flu, and swine flu. Based on end users, the market is trifurcated into ambulatories, clinics, and hospitals.
The hospitals segment may expand substantially owing to rising cases of chronic ailments and high awareness about disease prevention. A number of large and medium sized hospitals have begun adopting nanotechnology. Unlike small hospitals that have limited resources, the large ones can adopt newer technologies because of favorable budgetary conditions.
Geographically, the global industry is divided into Asia Pacific, North America, Europe, and Rest of the World. North America held the highest share in terms of revenue in 2014. Factors, such as high investments and sophisticated technologies can fuel this region in the forthcoming years. Ongoing industry trends suggest that Asia Pacific may register a high rate of growth at the same time. Key regional drivers are surging disposable incomes, outsourcing of healthcare services, and growing population.
Prominent companies operating in the worldwide healthcare nanotechnology market are Celgene Corporation, CombiMatrix Corporation, Johnson & Johnson, Abbott Laboratories,
Contact: + 1-800-489-3075
Email: sales @ hexaresearch. com Website: http:// www. hexaresearch. com /